Details of the Drug

General Information of Drug (ID: DMF16CU)

Drug Name

Vicasinabin

Synonyms

Vicasinabin; Vicasinabin [INN]; QJ8UO6C05M; RG7774; 1433361-02-4; RG-7774; (S)-1-(5-tert-Butyl-3-((1-methyl-1H-tetrazol-5-yl)methyl)-3H-(1,2,3)triazolo-(4,5-d)pyrimidin-7-yl)pyrrolidin-3-ol; 3-Pyrrolidinol, 1-(5-(1,1-dimethylethyl)-3-((1-methyl-1H-tetrazol-5-yl)methyl)-3H-1,2,3-triazolo(4,5-d)pyrimidin-7-yl)-, (3S)-; 3-Pyrrolidinol, 1-[5-(1,1-dimethylethyl)-3-[(1-methyl-1H-tetrazol-5-yl)methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-7-yl]-, (3S)-; VICASINABIN [USAN]; UNII-QJ8UO6C05M; SCHEMBL14912040; GTPL11890; EX-A8231; AKOS040756804; Example 151 [WO2013068306A1]; HY-145604; RO6868847; CS-0376695; RO-6868847; (3S)-1-(5-(1,1-Dimethylethyl)-3-((1-methyl-1H-tetrazol-5-yl)methyl)-3H-1,2,3-triazolo(4,5-d)pyrimidin-7-yl)-3-pyrrolidinol; (3S)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol; (3S)-1-{5-tert-butyl-3-[(1-methyl-1H-tetrazol-5-yl)methyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl{pyrrolidin-3-ol

Indication

Disease Entry	ICD 11	Status	REF
Diabetic retinopathy	9B71.0	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C15H22N10O
Canonical SMILES: CC(C)(C)C1=NC2=C(C(=N1)N3CCC(C3)O)N=NN2CC4=NN=NN4C
InChI: InChI=1S/C15H22N10O/c1-15(2,3)14-16-12(24-6-5-9(26)7-24)11-13(17-14)25(21-19-11)8-10-18-20-22-23(10)4/h9,26H,5-8H2,1-4H3/t9-/m0/s1
InChIKey: MAYZWDRUFKUGGP-VIFPVBQESA-N